ANTIMICROBIAL EFFECTS OF TRIMETHOPRIM AND SULPHADIAZINE IN INFECTED URINE AND BLOOD

References

1. Acar J. F., Goldstein F. W., Gerbaud G. R., Chabbert Y. A. 1977; Plasmides de résistance au triméthoprime: transferabilité et groupes d’incompatabilité. Annals Microbiol. 128A:41
   [Google Scholar]
2. Aizenberg O. A., Samoylenko I. I., Fradkin G. E. 1977; Role of the B⁺ gene product in thymineless death and characteristics of this phenomenon in a thy⁻recB⁻mutant of Escherichia coli K-12. Genetika 13:1988
   [Google Scholar]
3. Amyes S. G. B., Smith J. T. 1978; Trimethoprim antagonists: effect of uridine on thymine and thymidine uptake in mineral salt medium. J. antimicrob. Chemother 4:415
   [Google Scholar]
4. Anderson J. D., Lacey R. W., Lewis E. L., Sellin M. A. 1974; Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. J. clin. Path 27:619
   [Google Scholar]
5. Brumfitt W., Pursell R. 1972; Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in treatment or urinary infection. Br. med. J 2:673
   [Google Scholar]
6. Buick R. N., Harris W. J. 1975; Thymineless death in Bacillus subtilis. J. gen. Microbiol 88:115
   [Google Scholar]
7. Greenwood D., O’Grady F. 1976; Activity and interaction of trimethoprim and sulphamethoxazole against. Escherichia coli. J. clin. Path 29:162
   [Google Scholar]
8. Grey D., Hamilton-Miller J. M. T. 1977; Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole. J. med. Microbiol 10:273
   [Google Scholar]
9. Hitchings G. H. 1970; Trimethoprim: biochemical basis for sulphonamide potentiation. S. Afr. med. J., suppl 44:1
   [Google Scholar]
10. Kasanen A., Kaarsalo E., Hiltunen R., Soini V. 1974; Comparison of long-term low dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulpha-methoxazole on the control of recurrent urinary-tract infection. Ann. clin. Res 6:285
    [Google Scholar]
11. Koch U. J., Schumann K. P., Küchler R., Kewitz H. 1973; Efficacy of trimethoprim, sulphamethoxazole, and the combination of both in acute urinary tract infections: clinical and pharmacological studies. Chemotherapy 19:314
    [Google Scholar]
12. Lacey R. W. 1978; The suppression of the appearance of bacterial mutants by combined antibacterial therapy. J. antimicrob. Chemother 4:391
    [Google Scholar]
13. Lewis E. L., Anderson J. D., Lacey R. W. 1974; A reappraisal of the antibacterial action of cotrimoxazole in vitro. J. clin. Path 27:87
    [Google Scholar]
14. Mӓnnistӧ P., Tuomisto J., Saris N-E., Lehtinen T. 1973; Pharmacokinetic studies with trimethoprim and different doses of sulphadiazine in healthy human subjects. Chemotherapy 19:289
    [Google Scholar]
15. Nottebrock H., Then R. 1977; Thymidine concentrations in serum and urine of different animal species and man. Biochem. Pharmac 26:2175
    [Google Scholar]
16. Pinney R. J., Jacob A. E., Hedges R. W., Smith J. T. 1977; Dislodgement and thymineless elimination of N-group plasmids. Gentet. Res 30:21
    [Google Scholar]
17. Samanta H. K., Bhattacharjee S. B. 1977; Thymineless death in Escherichia coli. Z. Naturf 32:835
    [Google Scholar]
18. Stokes A., Lacey R. W. 1978; Effect of thymidine on activity of trimethoprim and sulphamethoxazole. J. clin. Path 31:165
    [Google Scholar]
19. Towner K. J., Pearson N. J., Cattell W. R., O’Grady F. 1978; Chromosomal resistance to trimethoprim. Lancet 1:1371
    [Google Scholar]
20. Tuomisto J., Kasanen A., Renkonen O-V. 1977; Sulphadiazine-trimethoprim combinations in the treatment of urinary tract infections. Chemotherapy 23:337
    [Google Scholar]